CAMBRIDGE, Mass., Jan. 4 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. announced today that management will present a corporate overview at the upcoming 28(th) Annual J. P. Morgan Healthcare Conference on Thursday, January 14, 2010 at 8:00 a.m. PT at the Westin St. Francis Hotel in San Francisco.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus. For further information about Idenix, please refer to http://www.idenix.com.
Idenix Pharmaceuticals Contact: Teri Dahlman (617) 995-9905
Idenix Pharmaceuticals, Inc.
